Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Seagen Inc.

SGEN•NASDAQ
Healthcare
Biotechnology
$228.74
$-0.16(-0.07%)
U.S. Market opens in 14h 7m

Seagen Inc. (SGEN) Stock Overview

Explore Seagen Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap43.2B
P/E Ratio-69.22
EPS (TTM)$-4.00
ROE-0.21%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$209.26

SGEN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Seagen Inc. (SGEN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $209.26.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -69.22 and a market capitalization of 43.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
-0.07%
3-Month Change
6.66%
6-Month Change
16.70%
Year-to-Date (YTD) Change
N/A
1-Year Change
73.24%
3-Year Change
26.82%
5-Year Change
225.19%
All-Time (Max) Change
2591.06%

Contact Information

https://www.seagen.com
425 527 4000
21823 30th Drive SE, Bothell, WA, 98021

Company Facts

32,560 Employees
IPO DateMar 9, 2001
CountryUS

Frequently Asked Questions